Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending April 17, 2018. The document serves as a transaction notification reporting changes in the notional interest of Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them. The transactions were executed on April 12, 2018, on the London Stock Exchange (XLON) and the New York Stock Exchange (XNYS).
Key Financial Metrics
The filing does not contain corporate financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively details share transaction volumes and prices for specific executives.
| Instrument | Price | Total Volume (Shares/ADSs) | Exchange |
|---|---|---|---|
| Ordinary Shares (GBP) | £14.296 | 67,530.682 | London Stock Exchange |
| American Depositary Shares (USD) | $40.62 | 12,472.899 | New York Stock Exchange |
Material Changes
The filing reports an increase in notional interest for 13 PDMRs. These increases resulted from the automatic re-investment of dividends paid to shareholders on April 12, 2018, into shares held within the Company's Performance Share Plan. There are no material changes to the company's operations, financial position, or capital structure reported in this document.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is strictly a regulatory disclosure of insider share plan activity.
Investor Verification Checklist
- Verify that the share price of £14.296 (GBP) and $40.62 (USD) aligns with the market price on April 12, 2018.
- Confirm that the transactions were executed under the Company's Performance Share Plan dividend re-investment mechanism.
- Note that these transactions represent an increase in notional interest, not open-market purchases by the executives.
- Review the specific roles of the 13 executives listed to understand the breadth of participation in the share plan.